Christopher Shen is listed as an executive officer and director on 12 SEC Form D filings by 10 issuers between Apr 2015 and Apr 2025. Largest by amount reported sold: Supira Medical, Inc. (Campbell, CA — other health care — 2025; $120M reported sold to 31 investors), Earlens Corp (Menlo Park, CA — other health care — 2016; $72.1M reported sold to 147 investors), Moximed, Inc (Fremont, CA — other health care — 2015–2017; $62.7M reported sold to 104 investors), Ivantis, Inc. (Irvine, CA — other technology — 2017; $58.9M reported sold to 14 investors), Element Science, Inc. (San Francisco, CA — other health care — 2020; $50.6M reported sold to 11 investors) and 5 more (all listed below).
What this means That is a lot of deals — 10 separate companies raised money with this person listed as executive officer and director, over about 10 years. Across those companies the filings report $471.9M sold in total.
Listed alongside Henry A. Plain, Jr. (7 shared filings), Robert W. Croce (3 shared filings), Ryan Drant (3 shared filings), Alexander Schmitz (2 shared filings), Arthur Franken (2 shared filings) and 56 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
The issuers belong to 3 sponsor groups: Qiming (3 issuers, $0 reported sold, 2017–2021), Supira (4 issuers, $219.8M reported sold, 2017–2025) and Med Tech Arbitrage (6 issuers, $67.5M reported sold, 2009–2026).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below. Not yet searched: SEC enforcement releases.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.